Back to Search Start Over

The Wide Spectrum of COVID-19 Clinical Presentation in Children

Authors :
Julien Jegard
Aurélie Schnuriger
Guillaume Aubertin
Chiara Sileo
Thibault Lecarpentier
Harriet Corvol
Guillaume Thouvenin
Nicolas Richard
Jessica Taytard
Nadia Nathan
Blandine Prevost
Laura Berdah
Isabelle Guellec
Sorbonne Université - Faculté de Médecine (SU FM)
Sorbonne Université (SU)
Physiopathologie des maladies génétiques d'expression pédiatrique (UMRS_933)
Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service de Pneumologie pédiatrique [CHU Trousseau]
CHU Trousseau [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Centre de Recherche Saint-Antoine (CR Saint-Antoine)
Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP]
Neurophysiologie Respiratoire Expérimentale et Clinique
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
Gestionnaire, Hal Sorbonne Université
Maladies génétiques d'expression pédiatrique [CHU Trousseau] (Inserm U933)
Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Trousseau [APHP]
Centre de Recherche Saint-Antoine (CRSA)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
Neurophysiologie Respiratoire Expérimentale et Clinique (UMRS 1158)
Mucoviscidose: physiopathologie et phénogénomique [CRSA]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
Source :
Journal of Clinical Medicine, Journal of Clinical Medicine, MDPI, 2020, 9 (9), pp.2950. ⟨10.3390/jcm9092950⟩, Volume 9, Issue 9, Journal of Clinical Medicine, Vol 9, Iss 2950, p 2950 (2020), Journal of Clinical Medicine, 2020, 9 (9), pp.2950. ⟨10.3390/jcm9092950⟩
Publication Year :
2020
Publisher :
HAL CCSD, 2020.

Abstract

Background: Ten months after its appearance in December 2019, SARS-CoV-2 has infected more than 25 million patients worldwide. Because children were first identified as potential spreaders of the virus, schools were closed in several countries. However, it rapidly became evident that the number of hospitalized children infected by SARS-CoV-2 was dramatically lower than that of adults. To date, only hypotheses have been raised to explain this difference, so it is of great importance to describe the presentation of this disease among children. Here, we describe a wide spectrum of COVID-19 manifestation in children in a dedicated pediatric unit in France. Methods: Patients hospitalized with COVID-19 who were diagnosed on the basis of either positive SARS-CoV-2 RT-PCR in nasopharyngeal swabs and/or typical aspects in chest-computed tomography (CT) were included between March and May 2020 in Paris. Results: Twenty-three patients were included on the basis of positive RT-PCR (n = 20) and/or typical aspects in CT (n = 4). The median age was 4.9 years [0.1&ndash<br />17.6]. Patients were grouped by age (&lt<br />2 years old: n = 14, 61%<br />2&ndash<br />10 years old: n = 2, 9%<br />&gt<br />10 years old: n = 7, 30%). Overweight or obesity was reported in only three patients. At presentation, the most frequent symptom in the overall cohort was fever (n = 18, 78%), followed by acute rhinitis (n = 9, 64%) and cough (n = 7, 50%) in the under 2-year-old group and cough (n = 4, 57%), fatigue, dyspnea and abdominal pain (n = 3, 43% each) in the over 10-year-old group. Five patients required ICU treatment, four of whom were aged &gt<br />10 years, two presented with acute myocarditis, and two were sickle cell disease patients who presented with acute chest syndrome. Discussion and conclusion: The youngest patients seem to present milder forms of COVID-19 without the need for ICU treatment and with a shorter length of hospitalization. More severe evolutions were observed in teenagers, with, however, favorable outcomes. Given the context of closed schools and confinement, the infection of these children suggests intra-familial transmission that needs to be further assessed. This description might help to understand the intriguing differences in COVID-19 severity across age-classes.

Details

Language :
English
ISSN :
20770383
Database :
OpenAIRE
Journal :
Journal of Clinical Medicine, Journal of Clinical Medicine, MDPI, 2020, 9 (9), pp.2950. ⟨10.3390/jcm9092950⟩, Volume 9, Issue 9, Journal of Clinical Medicine, Vol 9, Iss 2950, p 2950 (2020), Journal of Clinical Medicine, 2020, 9 (9), pp.2950. ⟨10.3390/jcm9092950⟩
Accession number :
edsair.doi.dedup.....735d0cc97938508c350a52a5dec1f3d1
Full Text :
https://doi.org/10.3390/jcm9092950⟩